Observational, non-interventional, longitudinal, prospective,multicenter, open label (No treatment is involved). 4 assessment will be carried out , in months 0, 1, 3 and 6. The primary objective is to asses evolution of subjective well-being and depressive symptoms in schizophrenic patients for six months after an acute episode treated in outpatient psychiatric units. The primary endpoint is: Total score in Subjective Well-being under Neuroleptic treatment (SWN-K) and Calgary Depression Rating Scale (CDRS) scales in assessment after 6 months vs baseline. Secondary objectives include: To evaluate the relationship between subjective well-being and psychopathology, subjective clinical global impression, adverse events and compliance of treatment. Also to compare the clinical global impression of psychiatrist and patient. In addiction to know the clinical, social and demographic factors involve in the subjective well-being and patient clinical global impression.
Study Type
OBSERVATIONAL
Enrollment
320
Research Site
Vitoria-Gasteiz, Alava, Spain
Research Site
Almansa, Albacete, Spain
Research Site
Alcoy, Alicante, Spain
Research Site
Alicante, Alicante, Spain
Research Site
Benidorm, Alicante, Spain
Research Site
El Ejido, Almeria, Spain
Research Site
Roquetas de Mar, Almeria, Spain
Research Site
Zafra, Badajoz, Spain
Research Site
Manacor, Balearic Islands, Spain
Research Site
Palma de Mallorca, Balearic Islands, Spain
...and 55 more locations
Total score in Subjective Well-being under Neuroleptic treatment (SWN-K) and Calgary Depression Rating Scale (CDRS) scales in assessment after 6 months vs baseline
Time frame: Months: 0, 1, 3 and 6
Patient Clinical Impression
Time frame: Months: 0, 1, 3 and 6
Clinical evaluation and social performance
Time frame: Months: 0, 1, 3 and 6
Adverse events reported by patients
Time frame: Months: 0, 1, 3 and 6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.